{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:02:54Z","timestamp":1758045774646,"version":"3.44.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873446"],"award-info":[{"award-number":["81873446"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.amjms.2023.07.005","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T11:03:17Z","timestamp":1689591797000},"page":"387-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hemophagocytic lymphohistiocytosis with a hemizygous PRF1 c.674G>A mutation"],"prefix":"10.1016","volume":"366","author":[{"given":"Xiangke","family":"Xin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2023.07.005_bib0001","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic Lymphohistiocytosis","volume":"13","author":"Al-Samkari","year":"2018","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"10.1016\/j.amjms.2023.07.005_bib0002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.iac.2008.01.010","article-title":"Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders","volume":"28","author":"Filipovich","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.amjms.2023.07.005_bib0003","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/cge.13363","article-title":"Genetic variant spectrum in 265 Chinese patients with hemophagocytic lymphohistiocytosis: molecular analyses of PRF1, UNC13D, STX11, STXBP2, SH2D1A, and XIAP","volume":"94","author":"Chen","year":"2018","journal-title":"Clin Genet"},{"issue":"6","key":"10.1016\/j.amjms.2023.07.005_bib0004","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s12519-020-00351-7","article-title":"Associations between PRF1 Ala91Val polymorphism and risk of hemophagocytic lymphohistiocytosis: a meta-analysis based on 1366 subjects","volume":"16","author":"Zhu","year":"2020","journal-title":"World J Pediatr"},{"issue":"12","key":"10.1016\/j.amjms.2023.07.005_bib0005","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nri1983","article-title":"Perforin-mediated target-cell death and immune homeostasis","volume":"6","author":"Voskoboinik","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"5446","key":"10.1016\/j.amjms.2023.07.005_bib0006","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.amjms.2023.07.005_bib0007","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in the form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.amjms.2023.07.005_bib0008","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","article-title":"Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11","volume":"85","author":"Zur Stadt","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.amjms.2023.07.005_bib0009","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/hmg\/ddi076","article-title":"Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11","volume":"14","author":"Zur Stadt","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.amjms.2023.07.005_bib0010","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1172\/JCI40732","article-title":"Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells","volume":"119","author":"Cote","year":"2009","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.amjms.2023.07.005_bib0011","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2249.2010.04302.x","article-title":"Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management","volume":"163","author":"Gholam","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.amjms.2023.07.005_bib0012","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/ijlh.13674","article-title":"Spectrum mutations of PRF1, UNC13D, STX11, and STXBP2 genes in Vietnamese patients with hemophagocytic lymphohistiocytosis","volume":"43","author":"Xinh","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"10.1016\/j.amjms.2023.07.005_bib0013","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3324\/haematol.2009.016949","article-title":"UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis","volume":"95","author":"Yoon","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.amjms.2023.07.005_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.975665","article-title":"Carrier frequency and incidence estimation of familial hemophagocytic lymphohistiocytosis in East Asian populations by genome aggregation database (gnomAD) based analysis","volume":"10","author":"Park","year":"2022","journal-title":"Front Pediatr"},{"issue":"10","key":"10.1016\/j.amjms.2023.07.005_bib0015","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41436-021-01203-z","article-title":"Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Gregg","year":"2021","journal-title":"Genet Med"},{"issue":"10","key":"10.1016\/j.amjms.2023.07.005_bib0016","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.12998\/wjcc.v9.i10.2289","article-title":"Adult onset type 2 familial hemophagocytic lymphohistiocytosis with PRF1 c.65delC\/c.163C>T compound heterozygous mutations: a case report","volume":"9","author":"Liu","year":"2021","journal-title":"World J Clin Cases"},{"issue":"1","key":"10.1016\/j.amjms.2023.07.005_bib0017","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1897-4287-9-9","article-title":"Molecular study of the perforin gene in familial hematological malignancies","volume":"9","author":"El Abed","year":"2011","journal-title":"Hered Cancer Clin Pract"},{"issue":"9","key":"10.1016\/j.amjms.2023.07.005_bib0018","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.4049\/jimmunol.1000102","article-title":"Gender-associated differences of perforin polymorphisms in the susceptibility to multiple sclerosis","volume":"185","author":"Camina-Tato","year":"2010","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.amjms.2023.07.005_bib0019","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.2337\/db07-0947","article-title":"Variations of the perforin gene in patients with type 1 diabetes","volume":"57","author":"Orilieri","year":"2008","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.amjms.2023.07.005_bib0020","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1097\/MPH.0000000000000102","article-title":"Unusual clinical presentations of familial hemophagocytic lymphohistiocytosis type-2","volume":"36","author":"Mhatre","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.amjms.2023.07.005_bib0021","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bcmd.2014.11.023","article-title":"Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis (FHL) patients in India","volume":"54","author":"Mhatre","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"11","key":"10.1016\/j.amjms.2023.07.005_bib0022","doi-asserted-by":"crossref","first-page":"e27929","DOI":"10.1002\/pbc.27929","article-title":"Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO)","volume":"66","author":"Jordan","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.amjms.2023.07.005_bib0023","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1046\/j.1365-2141.2001.02936.x","article-title":"Pathogenesis of haemophagocytic lymphohistiocytosis","volume":"114","author":"Arico","year":"2001","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.amjms.2023.07.005_bib0024","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/pro.2265","article-title":"Structural and functional analysis of perforin mutations in association with clinical data of familial hemophagocytic lymphohistiocytosis type 2 (FHL2) patients","volume":"22","author":"An","year":"2013","journal-title":"Protein Sci"},{"issue":"6","key":"10.1016\/j.amjms.2023.07.005_bib0025","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.leukres.2007.11.033","article-title":"Clinical and molecular aspects of Turkish familial hemophagocytic lymphohistiocytosis patients with perforin mutations","volume":"32","author":"Okur","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.amjms.2023.07.005_bib0026","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fimmu.2013.00072","article-title":"Elevated granzyme B in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosis","volume":"4","author":"Mellor-Heineke","year":"2013","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.amjms.2023.07.005_bib0027","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jmg.2007.052670","article-title":"Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations","volume":"45","author":"Trizzino","year":"2008","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.amjms.2023.07.005_bib0028","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jmg.2003.011528","article-title":"Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis","volume":"41","author":"Molleran Lee","year":"2004","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.amjms.2023.07.005_bib0029","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2141.2002.03266.x","article-title":"Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan","volume":"116","author":"Suga","year":"2002","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.amjms.2023.07.005_bib0030","article-title":"Genetic features of late onset primary hemophagocytic lymphohistiocytosis in adolescence or adulthood","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.amjms.2023.07.005_bib0031","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fimmu.2019.00395","article-title":"Pathogenic gene mutations or variants identified by targeted gene sequencing in adults with hemophagocytic lymphohistiocytosis","volume":"10","author":"Miao","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjms.2023.07.005_bib0032","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fgene.2020.00126","article-title":"Neurologic manifestations as initial clinical presentation of familial hemophagocytic lymphohistiocytosis Type2 due to PRF1 mutation in chinese pediatric patients","volume":"11","author":"Feng","year":"2020","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/j.amjms.2023.07.005_bib0033","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00432-020-03139-4","article-title":"Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry","volume":"146","author":"Birndt","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.amjms.2023.07.005_bib0034","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jaci.2015.06.048","article-title":"Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry","volume":"137","author":"Cetica","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjms.2023.07.005_bib0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.trsl.2015.12.004","article-title":"Search for the potential \u201csecond-hit\u201d mechanism underlying the onset of familial hemophagocytic lymphohistiocytosis type 2 by whole-exome sequencing analysis","volume":"170","author":"Gao","year":"2016","journal-title":"Transl Res"},{"issue":"22","key":"10.1016\/j.amjms.2023.07.005_bib0036","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1182\/blood-2011-07-370148","article-title":"Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.amjms.2023.07.005_bib0037","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1182\/blood-2014-05-573105","article-title":"Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis","volume":"124","author":"Zhang","year":"2014","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.amjms.2023.07.005_bib0038","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.1073\/pnas.0903815106","article-title":"Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer","volume":"106","author":"Chia","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.amjms.2023.07.005_bib0039","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1182\/blood-2004-08-3296","article-title":"Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte\/natural killer cell functions","volume":"105","author":"Ishii","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.amjms.2023.07.005_bib0040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ajh.20878","article-title":"Late-onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations","volume":"82","author":"Ueda","year":"2007","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.amjms.2023.07.005_bib0041","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S2352-3026(21)00366-5","article-title":"Malignancy-associated haemophagocytic lymphohistiocytosis","volume":"9","author":"Setiadi","year":"2022","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.amjms.2023.07.005_bib0042","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood.2019003664","article-title":"Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect","volume":"136","author":"Carvelli","year":"2020","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.amjms.2023.07.005_bib0043","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1473-3099(22)00348-6","article-title":"COVID-19, haemophagocytic lymphohistiocytosis, and infection-induced cytokine storm syndromes","volume":"22","author":"Spaner","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"19","key":"10.1016\/j.amjms.2023.07.005_bib0044","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjms.2023.07.005_bib0045","article-title":"Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome","volume":"2","author":"Chen","year":"2021","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.amjms.2023.07.005_bib0046","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1038\/s41467-021-24360-w","article-title":"Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity","volume":"12","author":"Vanderbeke","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.amjms.2023.07.005_bib0047","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1182\/asheducation-2013.1.605","article-title":"Hemophagocytic lymphohistiocytosis: pathogenesis and treatment","volume":"2013","author":"Janka","year":"2013","journal-title":"Hematology"},{"issue":"4","key":"10.1016\/j.amjms.2023.07.005_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.amjms.2023.07.005_bib0049","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/ejh.13593","article-title":"Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: a case series","volume":"106","author":"Hansen","year":"2021","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.amjms.2023.07.005_bib0050","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.3324\/haematol.2019.220301","article-title":"Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial","volume":"105","author":"Liang","year":"2020","journal-title":"Haematologica"},{"issue":"17","key":"10.1016\/j.amjms.2023.07.005_bib0051","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.amjms.2023.07.005_bib0052","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1182\/blood-2010-04-282392","article-title":"Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962923012594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962923012594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:43:17Z","timestamp":1757702597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962923012594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0002962923012594"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2023.07.005","relation":{},"ISSN":["0002-9629"],"issn-type":[{"type":"print","value":"0002-9629"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemophagocytic lymphohistiocytosis with a hemizygous PRF1 c.674G>A mutation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2023.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}